Further, a significant increase in MAS1 protein was detected in all tested pancreatic cancer cell lines (AsPC1, CFPAC1, and PANC1) after saMAS1+1982/AD treatment (Figure 2k). This evidence concerns the gene MAS1 and familial pancreatic carcinoma.